A detailed history of Cable Hill Partners, LLC transactions in Novartis Ag stock. As of the latest transaction made, Cable Hill Partners, LLC holds 11,383 shares of NVS stock, worth $1.26 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
11,383
Holding current value
$1.26 Million
% of portfolio
0.14%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 22, 2024

BUY
$92.57 - $107.37 $1.05 Million - $1.22 Million
11,383 New
11,383 $1.21 Million
Q3 2023

Oct 27, 2023

BUY
$94.73 - $105.13 $184,439 - $204,688
1,947 Added 23.92%
10,088 $1.03 Million
Q2 2023

Jul 19, 2023

BUY
$92.52 - $104.91 $67,632 - $76,689
731 Added 9.87%
8,141 $821,000
Q1 2023

May 04, 2023

SELL
$80.03 - $92.81 $272,342 - $315,832
-3,403 Reduced 31.47%
7,410 $681,000
Q4 2022

Feb 06, 2023

BUY
$75.55 - $92.52 $211,917 - $259,518
2,805 Added 35.03%
10,813 $980,000
Q3 2022

Nov 14, 2022

SELL
$74.61 - $87.26 $23,576 - $27,574
-316 Reduced 3.8%
8,008 $609,000
Q2 2022

Aug 11, 2022

BUY
$80.52 - $93.75 $114,660 - $133,500
1,424 Added 20.64%
8,324 $704,000
Q1 2022

May 16, 2022

BUY
$80.11 - $90.62 $49,988 - $56,546
624 Added 9.94%
6,900 $605,000
Q4 2021

Feb 11, 2022

BUY
$79.7 - $88.13 $65,752 - $72,707
825 Added 15.13%
6,276 $549,000
Q3 2021

Nov 16, 2021

BUY
$81.78 - $95.14 $61,498 - $71,545
752 Added 16.0%
5,451 $446,000
Q2 2021

Aug 13, 2021

SELL
$85.24 - $94.15 $21,736 - $24,008
-255 Reduced 5.15%
4,699 $429,000
Q1 2021

May 17, 2021

BUY
$83.5 - $98.47 $52,939 - $62,429
634 Added 14.68%
4,954 $423,000
Q4 2020

Feb 09, 2021

SELL
$78.07 - $94.43 $11,710 - $14,164
-150 Reduced 3.36%
4,320 $408,000
Q2 2020

Aug 13, 2020

SELL
$80.93 - $91.1 $24,683 - $27,785
-305 Reduced 6.39%
4,470 $390,000
Q1 2020

May 14, 2020

BUY
$70.67 - $99.01 $5,441 - $7,623
77 Added 1.64%
4,775 $394,000
Q4 2019

Feb 04, 2020

SELL
$84.35 - $95.37 $108,895 - $123,122
-1,291 Reduced 21.56%
4,698 $445,000
Q3 2019

Oct 29, 2019

SELL
$85.54 - $94.26 $60,476 - $66,641
-707 Reduced 10.56%
5,989 $520,000
Q2 2019

Aug 06, 2019

SELL
$75.4 - $92.8 $245,276 - $301,878
-3,253 Reduced 32.7%
6,696 $611,000
Q1 2019

May 10, 2019

SELL
$75.32 - $86.15 $110,871 - $126,812
-1,472 Reduced 12.89%
9,949 $956,000
Q4 2018

Feb 12, 2019

BUY
$73.66 - $82.02 $793,391 - $883,437
10,771 Added 1657.08%
11,421 $980,000
Q3 2018

Nov 14, 2018

SELL
$66.94 - $77.43 $17,739 - $20,518
-265 Reduced 28.96%
650 $56,000
Q2 2018

Aug 03, 2018

BUY
$64.91 - $73.36 $4,154 - $4,695
64 Added 7.52%
915 $69,000
Q1 2018

Apr 20, 2018

SELL
$70.39 - $84.15 $4,716 - $5,638
-67 Reduced 7.3%
851 $68,000
Q4 2017

Feb 22, 2018

SELL
$72.33 - $77.64 $27,268 - $29,270
-377 Reduced 29.11%
918 $79,000
Q3 2017

Oct 27, 2017

BUY
$74.14 - $77.27 $82,072 - $85,537
1,107 Added 588.83%
1,295 $112,000
Q2 2017

Aug 14, 2017

BUY
N/A
188
188 $15,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $238B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Cable Hill Partners, LLC Portfolio

Follow Cable Hill Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cable Hill Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cable Hill Partners, LLC with notifications on news.